Long Chain Fatty Acid Oxidation Disorders

2

Review clinical trials related to Long Chain Fatty Acid Oxidation Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Available

Expanded Access to Triheptanoin

Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.

Trial details
Biological sex: AllType: Expanded AccessSponsor: Ultragenyx Pharmaceutical IncUpdated: Apr 13, 2026
Eligibility criteria

Not listed

Status: Recruiting

Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders

In this study, the exercise tolerance in patients with long-chain fatty acid oxidation disorders (LcFAOD) will be compared to that of healthy volunteers who are carefully matched in terms of age, sex, BMI and physical activity score. The study aims to assess exercise capacity using cardiopulmonary exercise (CPX) tests and activity monitoring over a 7-day period. The hypothesis of the study is that LcFAOD patients will exhibit greater oxygen debt during short periods of exercise compared to healthy individuals. These findings will contribute to a better understanding of exercise intolerance in LcFAOD patients and may guide the development of targeted interventions, such as exercise training programs and enable the analysis of effectiveness of (new) treatments.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Updated: Aug 23, 2024Locations: 1
Eligibility criteria

Men and women (age ≥18 years) with a confirmed diagnosis of carnitine palmitoylt...

Pregnancy [+12]